Navigation Links
SDI Reports: Roughly Half of Patients Prescribed the Most Popular Osteoporosis Drugs Discontinue Therapy Within 6 Months -- Amgen's Prolia Offers New Dosing Option
Date:6/14/2010

According to SDI, about half of patients beginning therapy on popular osteoporosis drugs discontinue their treatment within 6 months. Amgen’s Prolia is the newest product to enter the market. Prolia differs from existing therapies as it is given every 6 months via injection.

(Vocus) June 14, 2010 -- According to a recent analysis by SDI, a leading healthcare market insight and analytics firm, about half of patients beginning therapy on popular osteoporosis drugs discontinue their treatment within 6 months. Amgen’s Prolia, which was recently approved for postmenopausal women with osteoporosis at high risk of fracture, or patients who could not tolerate other osteoporosis therapies, is the newest product to enter the market. Prolia differs from existing therapies as it is given every 6 months via injection.

Currently, alendronate, sometimes filled as Fosamax but more frequently as the generic equivalent, is the most popular treatment for osteoporosis. In the 12 months ending April 2010, alendronate accounted for almost 24% of drug issuances for the condition.

Generic alendronate is most often dispensed as a once-weekly therapy. SDI found that 49% of new alendronate patients had discontinued the drug 6 months later. Another 3% had switched to another therapy. After 12 months, 61% of new alendronate patients had discontinued therapy.    

The weekly form of Actonel had similar discontinuation rates. Fifty-four percent of patients taking Actonel once a week had discontinued therapy 6 months after starting; 64% had discontinued after 12 months.

The once-a-month version of Actonel fared slightly better after 6 months with only 47% of patients having discontinued therapy. But at 12 months, 63% had discontinued. The oral form
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Page: 1 2

Related medicine news :

1. SDI Reports: Pharmaceutical Promotion Spending Indicates Trend Toward Electronic and Online Promotion
2. SDI Reports: Hospital Outpatient Surgical Procedures Increasing, Surgery Centers Growing
3. SDI Reports: Emergency Room Visits Covered by Medicaid Increased 6% in 2009
4. SDI Reports: Nearly a Third Of Physicians Use Handheld and Smartphone Devices to Access Medical Information - Physicians Most Likely to be Using Apple iPhone
5. CNBC Presents 'Tom Brokaw Reports: BOOMER$!' on Thursday, March 4th at 9PM ET/PT
6. SIRIUS XM to Broadcast Doctor Radio Reports: Kids and Video Games - What You Should Know Before You Buy
7. Spinal cord stimulation may benefit Parkinsons patients
8. Brain MRI in children: Incidental findings yield disclosure dilemmas for doctors, patients
9. Study reveals causes of survival disparities based on insurance among rectal cancer patients
10. Uninsured more likely to die from trauma than patients with insurance, study finds
11. Intervention program helps breast cancer patients live longer after recurrence
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
SDI Reports: Roughly Half of Patients Prescribed the Most Popular Osteoporosis Drugs Discontinue Therapy Within 6 Months -- Amgen's Prolia Offers New Dosing Option
(Date:9/4/2015)... ... September 04, 2015 , ... The Schmidt National Law Group filed ... Paz. , Schmidt National Law Group, a leading firm in mass-tort litigation, has ... Bayer Corp., Bayer Essure, Inc., and other Bayer affiliates for injuries alleged to have ...
(Date:9/4/2015)... ... 04, 2015 , ... IVF New England, one of the largest and most ... Hour" in Manchester for women who wish to learn more about their fertility and ... and lounge, 827 Elm Street, Manchester, NH from 6PM to 7PM , This hip, ...
(Date:9/4/2015)... ... September 04, 2015 , ... After wearing the same uniforms for ... new apparel. In an effort to assist the team, the Jones Agency, a locally ... drive to raise funds for the new uniforms. , As is so often the ...
(Date:9/4/2015)... ... September 04, 2015 , ... A Union County charitable ... Core Compassion Project is a non-profit organization dedicated to offering Pilates scholarships to ... cancer treatments and recover their mobility, strength, and range of motion following breast ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... Keeping mold ... and around the home is quite common. Mold can grow anywhere - on carpet, ... leaking pipes. Checking for excessive moisture and water in the home is key to ...
Breaking Medicine News(10 mins):Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:IVF New England to Host ManchVegas New Hampshire Fertility Happy Hour on October 15, 2015 in Manchester for Women Who Wish to Learn More About Fertility and Egg Freezing 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 3Health News:Girl’s Night Out to Benefit Core Compassion Project, Located at the Beautiful, Morning Glory Farm 2Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4
... scientists at Bonn University have created a software system that ... //With the aid of the software, the visual prosthesis "learns" ... be interpreted by the brain. ,Nearly two dozens of ... implanted with a visual prosthesis. For this purpose, clinicians open ...
... Hormone Replacement Therapy (HRT), good or bad? //, Till ... menopausal women by giving them measured doses of female hormones, ... such as breast cancer, and heart disease often outweighed its ... mainly due to a 2002 study conducted for the prestigious ...
... to hospital research, almost 50 percent of Kenya’s gynecological ... wrong, often dangerous way. ,The research, ... in western Kenya, also observed that the sufferers were ... study, which appeared in the East African Medical Journal ...
... important lifeline of the growing Indian economy, Hollywood star Richard ... HIV.// ,"Since truck drivers stay out of home ... desires which finally ends up in spreading HIV. I have ... urging them to become responsible," Gere told reporters here Sunday. ...
... results of a new HIV drug has raised the prospect ... which the immune system begins to fail. // ,The ... least 178 patients with advanced HIV who were not responding ... HIV genetic material (RNA) in the blood of the patients ...
... predominantly composed of turmeric root extract and other spices ... a turmeric root extract, has been shown to possess ... sclerosis, and Alzheimer's disease. The molecular mechanism for its ... to inhibit the synthesis of MDM2, an oncoprotein known ...
Cached Medicine News:Health News:Software System to Improve the Function of Retinal Implants 2Health News:Software System to Improve the Function of Retinal Implants 3Health News:Hormone Replacement Therapy – To Choose Or No 2Health News:Improper Abortions- Kenyan Teenagers At Risk 2Health News:Anticancer Effects of Curcumin Revealed 2
(Date:9/4/2015)... Therapeutics, Inc. (Nasdaq: OREX ) today announced that management ... 2015 Healthcare Conference in Boston . The ... 2:30 p.m. Eastern Time. To listen to the live webcast ... section of the Company,s Web site at www.orexigen.com . ... event.  Orexigen Contact: , Media Contact: McDavid ...
(Date:9/4/2015)... 2015  PTC Therapeutics, Inc. (NASDAQ: PTCT ... its first-ever global awards program, the STRIVE Awards ... to aid nonprofit organizations that are committed to ... announcement is made as the global DMD community ... on Monday, September 7, 2015. "We ...
(Date:9/4/2015)... September 4, 2015 Oramed Pharmaceuticals ... clinical-stage pharmaceutical company focused on the development of oral ... participate in the upcoming Rodman & Renshaw 17 th ... 2015 in New York City . ... present a corporate overview on September 9, 2015. ...
Breaking Medicine Technology:PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 2PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 3PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 4Oramed to Present at the Rodman & Renshaw Global Investment Conference 2Oramed to Present at the Rodman & Renshaw Global Investment Conference 3
... Feb. 23, 2012   Talyst , a leader in ... was founded in 2002 and is dedicated to providing ... inventory control, enhanced workflow efficiency and improved patient safety. ... is committed to developing innovative products. The company partners ...
... 2012  Doctors and other healthcare professionals have grown increasingly concerned ... taking with regard to Fosamax - a widely used osteoporosis ... The FDA has so far resisted adding ... use. Such labels are necessary in light of the dangers ...
Cached Medicine Technology:Victims of Abnormal Bone Fractures Await Action as FDA Lingers on Edge of Tightening Fosamax Regulations 2
... a lightweight, easy-to-use repeater pipette, ... to 45 times in succession ... handle is adapted for seven ... dispensing volume range from 10 ...
... lightweight and balanced for smooth, one-handed control. ... comfort, reducing fatigue in even the longest ... physician to easily steer the catheter through ... one finger. Reflexion's auto-lock technology keeps the ...
Wire mesh braided design with a platinum core....
Inquire...
Medicine Products: